An expert group of public health practitioners and community representatives identify and discuss innovative and efficient methods for the collection and use of routine data in our HIV response.
An expert group of public health practitioners and community representatives identify and discuss innovative and efficient methods for the collection and use of routine data in our HIV response.
In March, we hosted colleagues from around the world at the 3rd international MeSH Symposium which took place at the beautiful Victoria Falls Safari Lodge in Victoria Falls, Zimbabwe. Here we summarise the key points of the symposium.
The Demystifying Key Words campaign’s first post discussed key populations – those populations who are at increased risk of HIV – and described why it’s important to understand their HIV prevention needs.
Presented by Dr Shona Dalal, World Health Organisation.
Dr Dalal will speak on the WHO HIV routine surveillance and incidence measurement guidelines she has been working on, and her personal experience in the field.
This is the fourth webinar part of the MeSH Webinar Series: Strengthening Routine HIV Data – A Female Researcher’s Perspective. Through a series of webinars running from August to November, discover the perspective and work of brilliant women in the HIV field.
This is the third webinar part of the MeSH Webinar Series: Strengthening Routine HIV Data – A Female Researcher’s Perspective.
This is the second webinar part of the MeSH Webinar Series: Strengthening Routine HIV Data – A Female Researcher’s Perspective.
By Sarah Bourdin.
I was delighted to join IAS 2021 and participate in the discussion of the current hot topics in the HIV research world. The event was packed full of inspiring talks, essential debates, and discussions.
This is the first webinar part of the MeSH Webinar Series: Strengthening Routine HIV Data – A Female Researcher’s Perspective.
We asked Neil Parkin from Data First Consulting, Inc and Veronica Miller from UC Berkeley and the Forum for Collaborative Research a few questions on the study and research behind the abstract “HIV recent infection test-based incidence as a counter-factual for new PrEP trials” for IAS2021.